Real-time Stock quotes, portfolio, LIVE TV and more.
|
Aug 07, 2012, 10.57 AM IST
Biocon has target of Rs 260, says Sudarshan Sukhani of s2analytics.com.
Biocon has target of Rs 260, says Sudarshan Sukhani of s2analytics.com.
Sukhani told CNBC-TV18, "Biocon’s immediate intraday short-term target is Rs 260. Biocon after a significant rally from Rs 200 reached Rs 260 and then consolidated. That consolidation should be resolved on the upside. Yesterday it saw big gains and that suggests that this is a consolidation and not a distribution." He further added, "In any case most stocks in this market are following the Nifty and if that is so then it’s not the immediate target. Once it crosses Rs 260-265 threshold then it has the potential to add significant momentum on the upside. So day trader should look for further gains today or build a position and maintain it." "The Nifty has made a bullish pattern and broken out and DLF did the same. So I would be upbeat on DLF. I would look at Rs 225 and say it could go even higher. Once momentum builds in the market a lot of things are just brushed aside." Disclosure: I have no personal holding in the above stocks.
|
News Videos
|